These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2677982)

  • 21. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
    [No Abstract]   [Full Text] [Related]  

  • 22. [Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections].
    Iakovlev SV; Polushkina NR; Iakovlev VP
    Ter Arkh; 2001; 73(11):15-22. PubMed ID: 11806197
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of pediatric infections with cefixime].
    Helwig H
    Infection; 1990; 18 Suppl 3():S147-9. PubMed ID: 2079376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
    Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections].
    Kobayashi H; Takamura K; Kono K; Onodera S; Sasaki N; Nagahama F; Kawakami Y; Honma Y; Matsuzaki M; Tanimura K
    Kansenshogaku Zasshi; 1984 Jun; 58(6):525-55. PubMed ID: 6436407
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacterial prevalence and antimicrobial prescribing trends for acute respiratory tract infections.
    Kronman MP; Zhou C; Mangione-Smith R
    Pediatrics; 2014 Oct; 134(4):e956-65. PubMed ID: 25225144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of newer fluoroquinolones in lower respiratory tract infections.
    Lode H; Allewelt M
    J Antimicrob Chemother; 2002 May; 49(5):709-12. PubMed ID: 12003962
    [No Abstract]   [Full Text] [Related]  

  • 28. A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections.
    Martin SJ; Jung R; Garvin CG
    Drug Saf; 2001; 24(3):199-222. PubMed ID: 11347723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolones as treatment for patients with lower respiratory tract infections caused by Streptococcus pneumoniae.
    Amyes SG; Thomson CJ
    J Antimicrob Chemother; 1998 Sep; 42(3):398-9. PubMed ID: 9786483
    [No Abstract]   [Full Text] [Related]  

  • 30. Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions.
    van Heijl I; Schweitzer VA; Zhang L; van der Linden PD; van Werkhoven CH; Postma DF
    Drugs Aging; 2018 May; 35(5):389-398. PubMed ID: 29663151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial agents in pulmonary infections.
    Murray BE; Moellering RC
    Med Clin North Am; 1980 May; 64(3):319-42. PubMed ID: 6993803
    [No Abstract]   [Full Text] [Related]  

  • 32. Short-Course antimicrobial therapy for upper respiratory tract infections.
    Guay DR
    Clin Ther; 2000 Jun; 22(6):673-84. PubMed ID: 10929916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Levofloxacin in the treatment of respiratory infections].
    Iakovlev SV; Iakovlev VP
    Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095
    [No Abstract]   [Full Text] [Related]  

  • 34. Improving adherence with antimicrobial therapy for respiratory tract infections: a discussion of directly observed therapy (DOT) and short-course therapies.
    Schwartz DB; Adler A; Dasaro AP; DeBellis RJ; Dick R; Ferro TJ; Krekun S; Malina RL; McKinnon PS; Volturo G
    Am J Ther; 2004; 11 Suppl 1():S18-21. PubMed ID: 23570158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The John Barnwell Lecture. The chemotherapy of bacterial respiratory infections.
    Crofton J
    Am Rev Respir Dis; 1970 Jun; 101(6):841-59. PubMed ID: 4914352
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effective treatment for infections of the upper and lower respiratory tract].
    Schapowal A
    Rev Med Suisse; 2009 Nov; 5(226):2364. PubMed ID: 20052873
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin.
    Nicolau DP
    Expert Opin Pharmacother; 2004 Feb; 5(2):229-35. PubMed ID: 14996620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial drugs and infections in ambulatory patients. Some problems and perspectives.
    McHenry MC; Weinstein AJ
    Med Clin North Am; 1983 Jan; 67(1):3-16. PubMed ID: 6338313
    [No Abstract]   [Full Text] [Related]  

  • 40. Current issues on resistance, treatment guidelines, and the appropriate use of fluoroquinolones for respiratory tract infections.
    Bishai W
    Clin Ther; 2002 Jun; 24(6):838-50; discussion 837. PubMed ID: 12117077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.